12 August 2019
Cambridge Cognition is pleased to announce its expansion into the Chinese market with the Company’s Cambridge Neuropsychological Test Automated Battery (“CANTAB”) computerised assessments. This move strengthens the Company’s global position, having announced a major opportunity in India earlier this year.
19 July 2019
Cambridge Cognition is pleased to announce the second commercial partnership with a leading pharmaceutical company, for its NeuroVocalixTM platform. NeuroVocalixTM is a unique voice biomarker technology and the product was launched last year and recently presented ground-breaking demonstrable evidence of the potential at a major global Alzheimer’s conference.
1 July 2019
Cambridge Cognition today announced the appointment of Debra Leeves as a Non-Executive Director with immediate effect.
24 May 2019
We’re pleased to announce that NHS Bedfordshire Clinical Commissioning Group (CCG) is introducing our iPad-based memory assessment tool into 50 general practices.
10 May 2019
The results of the 2019 CANTAB Research Grant are in! Once again we were overwhelmed by the quality of applications we received – which made it a tough job for our judging panel to narrow the research proposals down.
19 March 2019
Cambridge Cognition has announced a significant new contract providing digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.